COBOL is in the headlines again, and this time it is because of artificial intelligence (AI) – sparking conversations with tools emerging that claim t.

Tech workers are increasingly worried that the artificial intelligence they are building will replace them. But some are optimistic that it is just one more tool to work with. Though powerful, code ...

Nvidia's positions in these companies were relatively small at the end of the third quarter of 2025, but the chipmaker has spent recent years building a portfolio of AI‑related investments across ...

Anthropic just released the second Claude model upgrade this month. Claude Sonnet 4.6 is the first upgrade to Anthropic’s medium-sized AI model since version 4.5 arrived in September 2025. Anthropic ...

Americans are living in parallel AI universes. For much of the country, AI has come to mean ChatGPT, Google’s AI overviews, and the slop that now clogs social-media feeds. Meanwhile, tech hobbyists ...

Work is full of time-sucking, tedious or annoying tasks, particularly when you’re on a computer. I used to spend hours on stupid chores like reorganizing someone else’s messy spreadsheet. Now, I use ...

Anthropic has struck a deal to help redesign the computer-coding curricula taught in hundreds of community and state colleges, revving up the race among tech companies to get their AI tools into the ...

According to the music streaming platform Spotify and its co-CEO Gustav Söderström, the company's best developers "have not written a single line of code since December.” Yet Spotify continues to roll ...

Shares of Monday.com tanked earlier this week, but the company's vibe coding tool was a bright spot. Monday Vibe has reached $1 million in ARR faster than any other Monday.com product. By making it ...

We evaluate DeepCode on the PaperBench benchmark (released by OpenAI), a rigorous testbed requiring AI agents to independently reproduce 20 ICML 2024 papers from scratch. The benchmark comprises 8,316 ...

Recursion Pharmaceuticals crashed 90% but JPMorgan upgraded with $11 target implying near tripling. Eli Lilly partnered with Nvidia on a $1B AI drug discovery collaboration using Vera Rubin chips.

AI-assisted drug discovery isn't just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI age. Undoubtedly, it's no mystery as to why many wish to be underweight in ...